Frank A. Sinicrope, M.D.

  1. Gastroenterologist
  2. Internist
  3. Oncologist

Departments

Specialty Groups

Location

  1. Rochester, Minnesota

Languages

English
  1. Chemotherapy
  2. Immunotherapy
  • Colorectal cancer therapy including immunotherapy
  • Young onset cancer and hereditary cancer syndromes
  • Gastrointestinal cancers
Rochester

Rochester, Minnesota

  1. 2021
    MD - Leadership Development for Physicians in Academic Health Centers, Harvard UniversityHarvard University
  2. 1997
    Fellow - Medical OncologyUniversity of Texas M.D. Anderson Cancer Center
  3. 1992
    Research Fellowship - Gastroenterology, National Institutes of Health Research FellowUniversity of Chicago
  4. 1991
    Fellow - Gastroenterology/HepatologyUniversity of Chicago Hospitals
  5. 1989
    Resident - MedicineMichael Reese Hospital
  6. 1987
    Internship - MedicineMichael Reese Hospital
  7. 1985
    MDUniversity Of Chicago Pritzker School Of Medicine
  8. 1981
    AB - BiologyOccidental College

Certifications

  1. 1998
    Medical OncologyAmerican Board of Internal Medicine
  2. 1991
    GastroenterologyAmerican Board of Internal Medicine
  3. 1989
    Internal MedicineAmerican Board of Internal Medicine

Awards and honors

  1. 2019
    Honorary Professor of Tianjin Medical University, General Hospital Tianjin Medical University, General Hospital
  2. 2019
    Clinical Investigator of the Mayo Foundation Mayo Clinic Foundation
  3. 2013
    Visiting Professor of Host, Professor T. TakayamaTokushima University Hospital
  4. 2013
    Keynote Speaker - University of California San Diego, GI Research Symposium University of California San Diego
  5. 2012
    ESSO Winning Abstract 14th World Congress of Gastrointestinal Cancer
  6. 2009
    Visiting ProfessorVanderbilt University Digestive Disease Research Center
  7. 2009
    NCI Established Investigator Award in Cancer Prevention and Control (K05) National Cancer Institute
  8. 2000
    Visiting Professor at the University of South Carolina Cancer CenterUniversity of South Carolina Cancer Center
  9. 2000
    Visiting ProfessorSouth Carolina Cancer Center
  10. 1999
    Kadoorie Human Cancer Genetics Award from MD Anderson Cancer CenterMD Anderson Cancer Center
  11. 1999
    Kadoorie Human Cancer Genetics AwardUniversity of Texas M.D. Anderson Cancer Center
  12. 1998
    Advancement to Fellowship American College of Physicians
  13. 1997
    Student Research Award from the American Heart Association (Mentor, Professor R.J. Bing)American Heart Association
  14. 1997
    Clinical Oncology Career Development Award from American Cancer SocietyAmerican Cancer Society
  15. 1997
    Clinical Oncology Career Development AwardAmerican Cancer Society
  16. 1995
    Basic Science Research AwardGlaxo Institute for Digestive Health
  17. 1995
    Basic Science Research AwardGlaxo Institute for Digestive Health
  18. 1982
    Student Research AwardAmerican Heart Association
  19. 1981
    Graduated cum laudeOccidental College

Professional memberships

  1. 2022 - present
    Advisory MemberPathAI Organization
  2. 2022 - present
    Advisory MemberTargeted Oncology
  3. 2022 - present
    Advisory MemberEisai Pharmaceuticals Advisory Board
  4. 2021 - present
    MemberClinical Trials Work Group, EPIC Research Subcommittee
  5. 2021 - present
    Advisory MemberProtagonist Therapeutics
  6. 2020 - present
    Advisory BoardNational Cancer Institute, Colon Cancer Task Force
  7. 2019 - present
    Commiittee MemberAlliance for Clinical Trials in Oncology, Immunotherapy Committee
  8. 2019 - present
    Affiliate MemberGuardant Health, Inc., Eclipse Steering Committee
  9. 2019 - 2022
    Committee MemberASCO Conquer Cancer Grant Selection Committee
  10. 2019 - present
    MemberFamilial Cancer Cross Disciplinary Group
  11. 2018 - 2019
    Advisory MemberHalioDx,-Luminy Biotech Enterprises
  12. 2018 - present
    MemberCancer Care Models: Colorectal Cancer - Ask Mayo Expert
  13. 2017
    DirectorGI Translational Research Committee, Mayo Clinic/North Central Cancer Treatment Group
  14. 2017 - 2020
    Commiittee MemberAmerican Society of Clinical Oncology (ASCO) Program Committee
  15. 2017 - 2018
    Immuno-Oncology ConsultantBristol Meyers Squibb
  16. 2017
    Scientific Advisory BoardRoche Sequencing Solutions
  17. 2017
    Advisory MemberHoffman LaRoche/Genentech Scientific Advisory Board
  18. 2016
    Advisory MemberEMD Serono, Scientific Advisory Board
  19. 2015 - present
    Program LeaderGastrointestinal Cancer Research Program, Mayo Clinic Cancer Center - Rochester, Mayo Clinic Cancer Center
  20. 2014 - present
    Special Expert RepresentativeNational Cancer Institute, Gastrointestinal Cancer Steering Committee
  21. 2014 - present
    Vice ChairAlliance for Clinical Trials in Oncology, Prevention Committee
  22. 2013
    Scientific Advisory BoardBayer Pharmaceuticals
  23. 2012 - 2016
    Full MemberNCI Clinical Oncology (CONC) Study Section
  24. 2012 - present
    MemberCenter for Cell Signaling in Gastroenterology
  25. 2012 - present
    Board MemberAlliance for Clinical Trials in Oncology, Translational Research Executive Committee
  26. 2012 - present
    Commiittee MemberAlliance for Clinical Trials in Oncology, GI Committee
  27. 2012 - present
    Advisory MemberVentana Medical Systems
  28. 2011 - 2017
    AdvisorWorld Gastroenterology Organization, Task Force on Digestive Oncology
  29. 2011
    Commiittee MemberAACR Selection Committee for Landon Foundation-AACR Innovator Award for Cancer Prevention Research
  30. 2011 - 2014
    Executive Committee MemberGastrointestinal Cancer Research Program, Mayo Clinic Cancer Center - Rochester, Mayo Clinic Cancer Center
  31. 2010 - 2020
    Commiittee MemberAmerican Society of Clinical Oncology (ASCO) Program Committee
  32. 2010 - 2017
    Advisory RoleInternational Digestive Cancer Alliance Advisory Board
  33. 2010 - 2015
    Drug ConsultantThreshold Pharmaceuticals, Consultant Drug Consultant
  34. 2010 - 2011
    Ad Hoc ReviewerClinical Oncology (C-ONC) Study Section
  35. 2010 - present
    ChairAGA GI Oncology Committee for Prevention and Chemoprevention
  36. 2010
    Scientific Advisory BoardEMD Serono, Scientific Advisory Board
  37. 2010 - present
    MemberMayo Clinic Center for Cell Signaling in Gastroenterology
  38. 2009 - 2010
    AdvisorNational Cancer Institute Translational Research Task Force, GI Steering Committee
  39. 2008 - 2012
    Scientific CommitteeAmerican Society of Clinical Oncology, Cancer Prevention Scientific Program Committee
  40. 2008
    Ad Hoc ReviewerNCI SPORE (Specialized Programs of Research Excellence) Grants
  41. 2007 - 2010
    Panel MemberAGA, Research Awards Review Panel
  42. 2007 - 2010
    MemberResearch Awards Review Panel, American Gastroenterological Association
  43. 2007
    ReviewerSpecialized Programs of Research Excellence, National Cancer Institute, National Institutes of Health
  44. 2007 - present
    MemberScientific Advisory Committee, Mayo Clinic SPORE in Pancreatic Cancer, Mayo Clinic Cancer Center
  45. 2007 - present
    MemberGI Executive Committee, North Central Cancer Treatment Group
  46. 2006 - 2010
    MemberResearch Committee, Division of Gastroenterology and Hepatology, Department of Medicine
  47. 2005 - 2012
    Committee MemberNCI-Supported Colon Cancer Family Registry, Biospecimen Committee
  48. 2005 - present
    MemberColorectal Neoplasia Group, Division of Gastroenterology and Hepatology, Department of Internal Medicine
  49. 2004 - 2006
    Drug ConsultantScientific Advisory Board, Pfizer Pharmaceutical, Inc.
  50. 2004 - present
    MemberGI Translational Research Committee, Mayo Clinic/North Central Cancer Treatment Group
  51. 2004 - present
    Leader for Translational ResearchGI Subcommittee, North Central Cancer Treatment Group
  52. 2003
    Ad Hoc ReviewerNIH Cancer Epidemiology Study Section
  53. 2003 - present
    MemberMayo Clinic Division of Population Science
  54. 2003
    Ad Hoc ReviewerCancer Epidemiology Study Section, National Institutes of Health
  55. 2002 - present
    MemberMayo Clinic GIH Neoplasia Interest Group
  56. 2002 - 2013
    Committee MemberNorth Central Cancer Treatment Group, GI Executive Committee
  57. 2002 - present
    MemberMayo Clinic Comprehensive Cancer Center
  58. 2001 - 2008
    ConsultantNCI-Sponsored Phase III Trial, Data and Safety Monitoring Board
  59. 2001 - 2002
    MemberClinical Council Subcommittee on Clinical Research Funding, University of Texas M.D. Anderson Cancer Center
  60. 2001 - 2002
    MemberSteering Committee, GI Multidisciplinary Program, University of Texas M.D. Anderson Cancer Center
  61. 2001 - 2002
    MemberSteering Committee, Division of Cancer Prevention, University of Texas M.D. Anderson Cancer Center
  62. 2001 - 2002
    MemberColorectal Cancer Practice Guidelines, University of Texas M.D. Anderson Cancer Center
  63. 2001
    ConsultantData and Safety Monitoring Board, NCI-sponsored Phase III trial, University of California, Irvine
  64. 2001
    MemberUniversity of California, Irvine
  65. 2000
    External Grant ReviewerNIH External Reviewer, Site Visit for P01 Grant in Chemoprevention
  66. 2000 - 2001
    MemberMedical Practice Subcommittee, University of Texas M.D. Anderson Cancer Center
  67. 2000
    External ReviewerSite Visit for PO1 Grant in Chemoprevention, National Institutes of Health
  68. 2000
    MemberSite Visit for PO1 Grant in Chemoprevention, National Institutes of Health
  69. 2000
    MemberFaculty Achievement Award Selection Committee, University of Texas M.D. Anderson Cancer Center
  70. 1999 - 2002
    Committee MemberSouthwest Oncology Group, Cancer Control Research and Chemoprevention Committee
  71. 1999
    Commiittee MemberAmerican Association for Cancer Research, Selection Committee for DeWitt S. Goodman Annual Lecture
  72. 1999 - 2002
    MemberClinical Research Committee, University of Texas M.D. Anderson Cancer Center
  73. 1999 - 2001
    MemberAdvisory Committee for Institutional Grants and Contracts Database, University of Texas M.D. Anderson Cancer Center
  74. 1999
    MemberSelection Committee for DeWitt S. Goodman Annual Lecture, American Association for Cancer Research
  75. 1999
    MemberFaculty Search Committee, Department of Pathology, University of Texas M.D. Anderson Cancer Center
  76. 1999 - present
    MemberSouthwest Oncology Group
  77. 1999 - present
    MemberCancer Control Research Committee, Southwest Oncology Group
  78. 1999 - present
    MemberChemoprevention Subcommittee, Cancer Control Research Committee, Southwest Oncology Group
  79. 1998 - present
    FellowAmerican College of Physicians
  80. 1997 - present
    Committee MemberAmerican Gastroenterological Association, GI Oncology Committee
  81. 1997 - present
    MemberGI Oncology Committee, American Gastroenterological Association
  82. 1997 - present
    MemberAmerican Society of Clinical Oncology
  83. 1995 - 2002
    Quality Improvement ReviewerUniversity of Texas M.D. Anderson Cancer Center
  84. 1995 - present
    MemberAmerican Association for Cancer Research
  85. 1994 - 1998
    MemberCrohn's and Colitis Foundation of America
  86. 1993 - 2002
    MemberUniversity of Texas M.D. Anderson Cancer Center
  87. 1993 - 1994
    MemberParenteral Nutrition Support committee, University of Texas M.D. Anderson Cancer Center
  88. 1991 - present
    MemberAmerican Gastroenterological Association
  89. 1988 - 1990
    AssociateAmerican College of Physicians
  90. 1988 - present
    MemberAmerican College of Physicians
  91.  
    MemberMedical Advisory Board, Houston Gulf Coast/So. Texas Chapter, Crohn's and Colitis Foundation of America